Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Novel Diagnostics That Use Point-of-care Lateral Flow Testing Technology for Non-invasive, Individual Assessment of Antibody Protection to Tetanus and Vaccine Need

NCT07446166 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT07446166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07446166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Novel Diagnostics That Use Point-of-care Lateral Flow Testing Technology for Non-invasive, Individual Assessment of Antibody Protection to Tetanus and Vaccine Need
Lead sponsor
University of Birmingham
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 1, 2026
Completion date
February 1, 2028
Enrollment
390 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tetanus